MAPT and Alzheimer disease: In the triple transgenic AD mouse model that generated from cross-breeding of P301L tau transgenic pR5 mice and APPswePS2N141I double-transgenic APP152 mice, compromised mitochondrial function was notably observed (Rhein et al., 2009).